Breakthrough treatments and clinical trials do not always mean new technology but entirely new applications of existing technology. Last year, the IBD Center at Columbia enrolled the first patient in a nationwide study using the established technique of sacral nerve stimulation (SNS) in a new way: to treat Crohn’s Disease and ulcerative colitis, or IBD. A disease that affects over 3.5 million people in the United States.
SNS is a type of electrical stimulation therapy that uses a small device implanted in a pocket under the skin to stimulate the sacral nerve with a series of daily electrical pulses. This triggers stimulation similar to acupuncture and can eliminate the need for medications in IBD management.
After completion of the early feasibility phase, the BOOM-IBD trial is gearing up for the pivotal study. Click here to learn more about the device, research protocol, and trial eligibility: columbiasurgery.org/news/groundbreaking-study-treating-ibd-here-s-what-know-about-sacral-nerve-stimulation
25 июн 2024
